Dalfampridine
Brand name: Dalfampridine Er
Rank #321 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$34.1M
Total Cost
40,425
Total Claims
$34.1M
Total Cost
1,164
Prescribers
$844
Cost per Claim
3,487
Beneficiaries
52,621
30-Day Fills
$29K
Avg Cost/Provider
35
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$34.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $34.1M total
🔎 Data Overview
Average cost of $9,790 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Dalfampridine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mary Ann Picone | Neurology | Teaneck, NJ | 128 | $991K |
| 2 | Pamela Clark | Nurse Practitioner | Rochester, NY | 430 | $342K |
| 3 | Aimee Borazanci | Neurology | Phoenix, AZ | 59 | $301K |
| 4 | Malcolm Gottesman | Neurology | East Meadow, NY | 157 | $250K |
| 5 | Anna Cluskey | Physician Assistant | Milwaukee, WI | 55 | $243K |
| 6 | George Hutton | Neurology | Houston, TX | 39 | $240K |
| 7 | Anna Cluskey | Physician Assistant | Milwaukee, WI | 342 | $205K |
| 8 | Jamie Wolf | Nurse Practitioner | Waukesha, WI | 48 | $202K |
| 9 | Randall Trudell | Neurology | Knoxville, TN | 45 | $198K |
| 10 | Matthew Baker | Neurology | Naples, FL | 243 | $191K |
| 11 | Joseph Guarnaccia | Neurology | Derby, CT | 46 | $191K |
| 12 | Saud Sadiq | Neurology | New York, NY | 203 | $185K |
| 13 | George Hutton | Neurology | Houston, TX | 353 | $179K |
| 14 | Saud Sadiq | Neurology | New York, NY | 27 | $172K |
| 15 | Brian Steingo | Neurology | Boca Raton, FL | 26 | $166K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 318 | Isosorbide Mononitrate (Isosorbide Mononitrate Er) | $34.5M | 1,805,114 |
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology